Cancer Immunotherapy intermediate
Checkpoint Inhibitor TIGIT-antibody
Reference for checkpoint inhibitor TIGIT-antibody in peptide research.
By Encyclopeptide Editorial | 1 min read
checkpoint-inhibitor TIGIT-antibody checkpoint inhibitor cancer-immunotherapy
Overview
checkpoint inhibitor TIGIT-antibody is a peptide studied in cancer immunotherapy research.
Properties
| Property | Value |
|---|---|
| Parent | checkpoint-inhibitor |
| Variant | TIGIT-antibody |
| Type | Checkpoint inhibitor |
| Category | Cancer Immunotherapy |
Significance
This checkpoint inhibitor has been investigated for its biological activity and therapeutic potential.
References
- Encyclopeptide Database. “checkpoint-inhibitor-TIGIT-antibody” monograph. encyclopeptide.com.
Chemical Identity
| Property | Value |
|---|---|
| Name | Checkpoint Inhibitor TIGIT-antibody |
| Category | Cancer Immunotherapy |
Test Your Knowledge
Reinforce what you learned about Checkpoint Inhibitor TIGIT-antibody with interactive quizzes on Wikipept.
Take a Quiz on Wikipept